249 related articles for article (PubMed ID: 11364428)
1. Leishmaniasis in HIV-infected persons: a review.
Paredes R; Laguna F; Clotet B
J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):22-39. PubMed ID: 11364428
[TBL] [Abstract][Full Text] [Related]
2. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Ali A
Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
[TBL] [Abstract][Full Text] [Related]
3. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
Gravino AE
Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
[TBL] [Abstract][Full Text] [Related]
4. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana.
Couppié P; Clyti E; Sobesky M; Bissuel F; Del Giudice P; Sainte-Marie D; Dedet JP; Carme B; Pradinaud R
Br J Dermatol; 2004 Dec; 151(6):1165-71. PubMed ID: 15606511
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics.
Ameen M
Clin Exp Dermatol; 2010 Oct; 35(7):699-705. PubMed ID: 20831602
[TBL] [Abstract][Full Text] [Related]
7. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.
Goto H; Lindoso JA
Expert Rev Anti Infect Ther; 2010 Apr; 8(4):419-33. PubMed ID: 20377337
[TBL] [Abstract][Full Text] [Related]
8. [Leishmaniasis and human immunodeficiency virus: an emerging co-infection?].
Marlier S; Menard G; Gisserot O; Kologo K; De Jaureguiberry JP
Med Trop (Mars); 1999; 59(2):193-200. PubMed ID: 10546196
[TBL] [Abstract][Full Text] [Related]
9. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
10. [Visceral leishmaniasis in patient with HIV infection].
Olea P; Pinilla J
Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
[TBL] [Abstract][Full Text] [Related]
11. [Visceral leishmaniasis and HIV infection in the HAART era].
Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A
Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
Antinori S; Calattini S; Longhi E; Bestetti G; Piolini R; Magni C; Orlando G; Gramiccia M; Acquaviva V; Foschi A; Corvasce S; Colomba C; Titone L; Parravicini C; Cascio A; Corbellino M
Clin Infect Dis; 2007 Jun; 44(12):1602-10. PubMed ID: 17516404
[TBL] [Abstract][Full Text] [Related]
13. Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV.
Borrelli P; Imperato A; Murdaca G; Scudeletti M
Ann Ital Med Int; 2000; 15(2):169-71. PubMed ID: 10920508
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
Pourahmad M; Hooshmand F; Rahiminejad M
Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
[TBL] [Abstract][Full Text] [Related]
15. Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome.
Sinha S; Fernández G; Kapila R; Lambert WC; Schwartz RA
Int J Dermatol; 2008 Dec; 47(12):1263-70. PubMed ID: 19126013
[TBL] [Abstract][Full Text] [Related]
16. [Parasite identification in the surveillance of imported leishmaniasis cases in Italy].
Gramiccia M; Di Muccio T; Marinucci M
Parassitologia; 2004 Jun; 46(1-2):207-10. PubMed ID: 15305718
[TBL] [Abstract][Full Text] [Related]
17. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
[TBL] [Abstract][Full Text] [Related]
18. [Disseminated cutaneous leishmaniasis revealing human immunodeficiency virus infection].
Durand I; Beylot-Barry M; Weill FX; Doutre MS; Beylot C
Ann Dermatol Venereol; 1998 Apr; 125(4):268-70. PubMed ID: 9747266
[TBL] [Abstract][Full Text] [Related]
19. Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report.
Calza L; Marinacci G; Manfredi R; Colangeli V; Fortunato L; Chiodo F
J Chemother; 2001 Dec; 13(6):653-7. PubMed ID: 11806628
[TBL] [Abstract][Full Text] [Related]
20. Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
Patel TA; Lockwood DN
Trop Med Int Health; 2009 Sep; 14(9):1064-70. PubMed ID: 19552658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
